Expression of delta opioid receptor mRNA and protein in the rat cerebral cortex and cerebellum is decreased by growth hormone

Journal of Neuroscience Research

Volumn 71, Issue 4, 2003, Pages 496-503

  Persson, Anders I ^a   Åberg, N David ^a   Oscarsson, Jan ^a   Isaksson, Olle G P ^a   Rönnbäck, Lars ^a   Frick, Fredrik ^a   Sonesson, Christian ^a   Eriksson, Peter S ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Brain; DOR; GH; Hypophysectomy; Rat

Indexed keywords

DELTA OPIATE RECEPTOR; HYDROCORTISONE; HYDROCORTISONE SODIUM SUCCINATE; LEVOTHYROXINE; MESSENGER RNA; RECOMBINANT GROWTH HORMONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CONTROLLED STUDY; DENSITOMETRY; FEMALE; HORMONE ACTION; HORMONE RELEASE; HYBRIDIZATION; HYPOPHYSECTOMY; HYPOPHYSIS; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RIBONUCLEASE PROTECTION ASSAY; WESTERN BLOTTING;

ANIMALS; CATTLE; CEREBELLUM; CEREBRAL CORTEX; FEMALE; GENE EXPRESSION REGULATION; GROWTH HORMONE; PROTEIN BIOSYNTHESIS; PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; RNA, MESSENGER;

EID: 0037441544     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10515     Document Type: Article

References (49)

1. Åberg ND, Carlsson B, Rosengren L, Oscarsson J, Isaksson OG, Ronnback L, Eriksson PS. 2000. Growth hormone increases connexin-43 expression in the cerebral cortex and hypothalamus. Endocrinology 141:3879-3886.
2. Abeyta A, Dettmer TS, Barnes A, Vega D, Carta M, Gallegos N, Raymond-Stintz M, Savage DD, Valenzuela CF, Saland LC. 2002. Delta opioid receptor localization in the rat cerebellum. Brain Res 931:100-105.
3. Armstrong CS, Wuarin L, Ishii DN. 2000. Uptake of circulating insulinlike growth factor-I into the cerebrospinal fluid of normal and diabetic rats and normalization of IGF-II mRNA content in diabetic rat brain. J Neurosci Res 59:649-660.
4. 125I-beta-endorphin cross-linked products in subcellular fractions from NG108-15 cells. Biochemistry 35:14818-14824.
5. Bengtsson BA, Eden S, Lonn L, Kvist H, Stokland A, Lindstedt G, Bosaeus I, Tolli J, Sjostrom L, Isaksson OG. 1993. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 76:309-317.
6. Brady LS, Herkenham M, Rothman RB, Partilla JS, Konig M, Zimmer AM, Zimmer A. 1999. Region-specific up-regulation of opioid receptor binding in enkephalin knockout mice. Brain Res Mol Brain Res 68:193-197.
7. Cahill CM, McClellan KA, Morinville A, Hoffert C, Hubatsch D, O'Donnell D, Beaudet A. 2001a. Immunohistochemical distribution of delta opioid receptors in the rat central nervous system: evidence for somatodendritic labeling and antigen-specific cellular compartmentalization. J Comp Neurol 440:65-84.
8. Cahill CM, Morinville A, Lee MC, Vincent JP, Collier B, Beaudet A. 2001b. Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception. J Neurosci 21:7598-7607.
9. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
10. Cox DR, Hinkley DV. 1974. Theoretical statistics. Boca Raton, FL: Chapman and Hall. p 179.
11. Cvejic S, Devi LA. 1997. Dimerization of the delta opioid receptor: implication for a role in receptor internalization. J Biol Chem 272:26959-26964.
12. Evans CJ, Keith DE Jr, Morrison H, Magendzo K, Edwards RH. 1992. Cloning of a delta opioid receptor by functional expression [see comments]. Science 258:1952-1955.
13. George SR, Fan T, Xie Z, Tse R, Tam V, Varghese G, O'Dowd BF. 2000. Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. J Biol Chem 275:26128-26135.
14. Gevers EF, Wit JM, Robinson IC. 1996. Growth, growth hormone (GH)-binding protein, and GH receptors are differentially regulated by peak and trough components of the GH secretory pattern in the rat. Endocrinology 137:1013-1018.
15. Gossard F, Dihl F, Pelletier G, Dubois PM, Morel G. 1987. In situ hybridization to rat brain and pituitary gland of growth hormone cDNA. Neurosci Lett 79:251-256.
16. Hauser KF, Houdi AA, Turbek CS, Elde RP, Maxson W 3rd. 2000. Opioids intrinsically inhibit the genesis of mouse cerebellar granule neuron precursors in vitro: differential impact of mu and delta receptor activation on proliferation and neurite elongation. Eur J Neurosci 12: 1281-1293.
17. 3H]DSLET binding: evidence for distinct delta 1 and delta 2 opioid receptor populations in rat brain. Brain Res 719:85-95.
18. Hojvat S, Emanuele NV, Kirsteins L, Lawrence AM. 1986. Impact of endocrine manipulations on brain-based rat growth hormone. Neuroendocrinology 44:355-360.
19. Jansson JO, Albertsson-Wikland K, Eden S, Thorngren KG, Isaksson O. 1982. Circumstantial evidence for a role of the secretory pattern of growth hormone in control of body growth. Acta Endocrinol 99:24-30.
20. Jenab S, Kest B, Franklin SO, Inturrisi CE. 1995. Quantitative distribution of the delta opioid receptor mRNA in the mouse and rat CNS. Life Sci 56:2343-2355.
21. Johansson JO, Larson G, Andersson M, Elmgren A, Hynsjo L, Lindahl A, Lundberg PA, Isaksson OG, Lindstedt S, Bengtsson BA. 1995. Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters. Neuroendocrinology 61:57-66.
22. Jordan BA, Devi LA. 1999. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399:697-700.
23. Keller SE, Schleifer SJ, Liotta AS, Bond RN, Farhoody N, Stein M. 1988. Stress-induced alterations of immunity in hypophysectomized rats. Proc Natl Acad Sci USA 85:9297-9301.
24. Kim KW, Kim SJ, Shin BS, Choi HY. 2001. Ligand binding profiles of delta-opioid receptor in human cerebral cortex membranes: evidence of delta-opioid receptor heterogeneity. Life Sci 68:1649-1656.
25. 125IPhe4,D-Pen5]enkephalin: a selective high affinity radioligand for delta opioid receptors with exceptional specific activity. J Pharmacol Exp Ther 258:1077-1083.
26. Lobie PE, Garcia-Aragon J, Lincoln DT, Barnard R, Wilcox JN, Waters MJ. 1993. Localization and ontogeny of growth hormone receptor gene expression in the central nervous system. Brain Res Dev Brain Res 74:225-233.
27. Lowry OH, Rosebrough BJ, Farr AL, Randall RJ. 1951. Protein measurement with folin phenol reagent. J Biol Chem 193:265-275.
28. Mansour A, Fox CA, Akil H, Watson SJ. 1995. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 18:22-29.
29. McGauley GA. 1989. Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency. Acta Paediatr Scand Suppl 356:70-72 [discussion p 73].
30. Miller BC. 1998. Western blot analysis of the delta (delta)-opioid receptor in activated murine T cells. Adv Exp Med Biol 437:159-167.
31. Minami S, Kamegai J, Sugihara H, Hasegawa O, Wakabayashi I. 1992. Systemic administration of recombinant human growth hormone induces expression of the c-fos gene in the hypothalamic arcuate and periventricular nuclei in hypophysectomized rats. Endocrinology 131:247-253.
32. Mustafa A, Sharma HS, Olsson Y, Gordh T, Thoren P, Sjoquist PO, Roos P, Adem A, Nyberg F. 1995. Vascular permeability to growth hormone in the rat central nervous system after focal spinal cord injury. Influence of a new anti-oxidant H 290/51 and age. Neurosci Res 23:185-194.
33. Negri L, Potenza RL, Corsi R, Melchiorri P. 1991. Evidence for two subtypes of delta opioid receptors in rat brain. Eur J Pharmacol 196:335-336.
34. Negri L, Lattanzi R, Borsodi A, Toth G, Salvadori S. 1999. Differential knockdown of delta-opioid receptor subtypes in the rat brain by antisense oligodeoxynucleotides targeting mRNA. Antisense Nucleic Acid Drug Dev 9:203-211.
35. Ogawa N, Panerai AE, Lee S, Forsbach G, Havlicek V, Friesen HG. 1979. Beta-endorphin concentration in the brain of intact and hypophysectomized rats. Life Sci 25:317-326.
36. Oscarsson J, Olofsson SO, Bondjers G, Eden S. 1989. Differential effects of continuous vs. intermittent administration of growth hormone to hypophysectomized female rats on serum lipoproteins and their apoproteins. Endocrinology 125:1638-1649.
37. Persson PA, Thorlin T, Ronnback L, Hansson E, Eriksson PS. 2000. Differential expression of delta opioid receptors and mRNA in proliferating astrocytes during the cell cycle. J Neurosci Res 61:371-375.
38. Peterson GL. 1977. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83:346-356.
39. Sar M, Stumpf WE, Miller RJ, Chang KJ, Cuatrecasas P. 1978. Immunohistochemical localization of enkephalin in rat brain and spinal cord. J Comp Neurol 182:17-37.
40. Schneider-Rivas S, Rivas-Arancibia S, Vazquez-Pereyra F, Vazquez-Sandoval R, Borgonio-Perez G. 1995. Modulation of long-term memory and extinction responses induced by growth hormone (GH) and growth hormone releasing hormone (GHRH) in rats. Life Sci 56:PL433-PL441.
41. Sjoberg A, Oscarsson J, Bostrom K, Innerarity TL, Eden S, Olofsson SO. 1992. Effects of growth hormone on apolipoprotein-B (apoB) messenger ribonucleic acid editing, and apoB 48 and apoB 100 synthesis and secretion in the rat liver. Endocrinology 130:3356-3364.
42. Stern WC, Miller M, Jalowiec JE, Forbes WB, Morgane PJ. 1975. Effects of growth hormone on brain biogenic amine levels. Pharmacol Biochem Behav 3:1115-1118.
43. Takemori AE, Portoghese PS. 1993. Enkephalin antinociception in mice is mediated by delta 1- and delta 2-opioid receptors in the brain and spinal cord, respectively. Eur J Pharmacol 242:145-150.
44. Thorlin T, Eriksson PS, Persson PA, Aberg ND, Hansson E, Ronnback L. 1998. Delta-opioid receptors on astroglial cells in primary culture: mobilization of intracellular free calcium via a pertussis sensitive G protein. Neuropharmacology 37:299-311.
45. Thomgren KG, Hansson LI. 1973. Effect of thyroxine and growth hormone on longitudinal bone growth in the hypophysectomized rat. Acta Endocrinol 74:24-40.
46. Tseng LF, Tsai JH, Collins KA, Portoghese PS. 1995. Spinal delta 2-, but not delta 1-, mu-, or kappa-opioid receptors are involved in the tail-flick inhibition induced by beta-endorphin from nucleus raphe obscurus in the pentobarbital-anesthetized rat. Eur J Pharmacol 277:251-256.
47. Vathy I, Rimanoczy A, Slamberova R. 2000. Prenatal exposure to morphine differentially alters gonadal hormone regulation of delta-opioid receptor binding in male and female rats. Brain Res Bull 53:793-800.
48. Wood TL, Berelowitz M, Gelato MC, Roberts CT Jr, LeRoith D, Millard WJ, McKelvy JF. 1991. Hormonal regulation of rat hypothalamic neuropeptide mRNAs: effect of hypophysectomy and hormone replacement on growth-hormone-releasing factor, somatostatin and the insulin-like growth factors. Neuroendocrinology 53:298-305.
49. Ye P, Umayahara Y, Ritter D, Bunting T, Auman H, Rotwein P, D'Ercole AJ. 1997. Regulation of insulin-like growth factor I (IGF-I) gene expression in brain of transgenic mice expressing an IGF-I-luciferase fusion gene. Endocrinology 138:5466-5475.